Human Defensins Inhibit SARS-CoV-2 Infection by Blocking Viral Entry
Article
[키워드] activities
acute infection
acute respiratory syndrome
anti-SARS-CoV-2
Anti-SARS-CoV-2 Activity
antimicrobial peptides
Antiviral
antiviral activity
binding
blocked
blocking
Cell
contribute
COVID-19 disease
Critical
defensin
Defensins
Effect
epithelial cells
exhibited
expressing
Factor
form
hACE2
had no
HNP1
Human
Immunity
Infection
inhibited
Innate
innate immune
intestinal
investigated
linear
Lung epithelial cells
MERS
Middle East
neutrophil
outcomes
Paneth cells
peptide
peptides
Post-infection
precursor
protective effect
provided
Pseudotyped virus
replication-competent SARS-CoV-2
reported
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 spike proteins
SARS-CoV-2 variants
severity
spike receptor-binding domain
syndrome
the disease
viral entry
viral infection
virion
virus
virus titer
β-defensin
[DOI] 10.3390/v13071246 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/v13071246 PMC 바로가기 [Article Type] Article